Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00127777
Status:
UNKNOWN
Last Update Posted:
2005-08-25
First Post:
2005-08-04
Brief Title:
Peginterferon Alfa-2a Ribavirin AmantadinePlacebo in Hepatitis C Virus HCV-Genotype-1-Infection PRAMA
Sponsor:
University Hospital Saarland
Organization:
University Hospital Saarland
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-07
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2006-12
Completion Date Type:
None
First Submit Date:
2005-08-04
First Submit QC Date:
August 4 2005
Study First Post Date:
2005-08-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2005-08-24
Last Update Post Date:
2005-08-25
Last Update Post Date Type:
ESTIMATED